Overview
Dr. Jennifer Ligibel is a Professor at Harvard Medical School, the Director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living, and the Director of the Center for Faculty Well-Being at the Dana-Farber Cancer Institute. Dr. Ligibel’s research focuses on the impact of lifestyle interventions upon cancer-related outcomes in women with breast cancer. She has conducted a number of studies looking at the impact of exercise and weight loss interventions upon patients’ quality of life and symptoms after cancer diagnosis and is currently leading an NCI-funded Phase III clinical trial that will test the impact of a weight loss intervention upon the risk of disease recurrence in more than 3000 overweight and obese women with early-stage breast cancer. Dr. Ligibel was the Chair of the American Society of Clinical Oncology Subcommittee on Energy Balance, which has developed patient and physician materials to help facilitate healthy lifestyle changes after cancer diagnosis.
Dr. Ligibel is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Hormone Replacement Therapy (HRT).
Her clinical research consists of co-authoring 199 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Hormone Replacement Therapy (HRT).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
450 Brookline Avenue, Susan F. Smith Center For Women's Cancers, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Brigham And Women's Hospital, Division Of Breast Surgery
Dr. Partridge received her MD from Cornell University Medical College in 1995. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and went on to complete fellowships in medical oncology and hematology at DFCI, MGH and BWH. She also received an MPH from Harvard School of Public Health. She is a medical oncologist who cares for adults with breast cancer, with a particular focus on the unique needs of young patients with breast cancer. She also leads efforts to optimize cancer survivorship care and research at DFCI. She completed fellowships in Medical Oncology and Hematology at DFCI, Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Partridge is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, HER-2 Positive Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.
Beth Israel Deaconess Medical Center - Hematology/Oncology
Nadine Tung is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Tung is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Breast Cancer, Ovarian Cancer, BRCA Positive Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT).
Dana-Farber Cancer Institute, Inc.
Rachel Freedman is an Oncologist in Boston, Massachusetts. Dr. Freedman is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Breast Cancer, Breast Cancer in Men, Angiosarcoma, Inflammatory Breast Cancer, and Hormone Replacement Therapy (HRT). Dr. Freedman is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Ligibel isElite. Learn about Breast Cancer.
- Distinguished
- AngiosarcomaDr. Ligibel isDistinguished. Learn about Angiosarcoma.
- Inflammatory Breast CancerDr. Ligibel isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Ligibel isDistinguished. Learn about Paget Disease of the Breast.
- Experienced
- Brain TumorDr. Ligibel isExperienced. Learn about Brain Tumor.
- Colorectal CancerDr. Ligibel isExperienced. Learn about Colorectal Cancer.
- Familial Prostate CancerDr. Ligibel isExperienced. Learn about Familial Prostate Cancer.
- Hormone Replacement Therapy (HRT)Dr. Ligibel isExperienced. Learn about Hormone Replacement Therapy (HRT).
- MenopauseDr. Ligibel isExperienced. Learn about Menopause.
- Ovarian CancerDr. Ligibel isExperienced. Learn about Ovarian Cancer.